Integrated efficacy analysis from phase 3 studies of investigational microbiome therapeutic, SER-109, in recurrent Clostridioides difficile infection.
| Autor: | Sims, Matthew, Silverman, Michael, Louie, Thomas, Wang, Elaine, Kraft, Colleen, Ramesh, Mayur, Bogdanovich, Tatiana, Brady, Kelly, Lombardi, David, Memisoglu, Asli, De, Ananya, Hasson, Brooke, Lee, Christine, Feuerstadt, Paul, Pardi, Darrell, Kelly, Colleen, Daley, Peter, Oguchi, Godson, McGovern, Barbara, Moltke, Lisa Von |
|---|---|
| Zdroj: | Antimicrobial Stewardship & Healthcare Epidemiology; 2024 Supplement, Vol. 3, ps5-s5, 1p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|